Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil in patients with metastatic renal cell cancer.

Rini BI, Vogelzang NJ, Dumas MC, Wade JL, Taber DA, Stadler WM. Phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil in patients with metastatic renal cell cancer. J Clin Oncol. 2000 Jun; 18(12):2419-26.

View in: PubMed

collapse authors with profiles